Sars-CoV-2 infection causes thrombocytes to attach to the blood platelets. This creates cell aggregates in the bloodstream.

Image source: Adobe Stock/Axel Kock

News • Based on image-based flow cytometry

Rapid test to predict severe Covid-19 infections

Researchers at the Technical University of Munich (TUM) have developed a method for rapidly assessing the number and structure of aggregated thrombocytes.

As a result, they have identified a predictive biomarker for the seriousness of a Covid-19 infection. This will allow physicians to adjust treatment at an early stage. The researchers used a method from image-based flow cytometry that permits the rapid analysis of interactions between large numbers of blood cells. 

The team published their findings in the journal Communications Medicine

Oliver Hayden is Professor of Biomedical Electronics and develops novel methods for in-vitro diagnostic and biomedical issues as part of his research.

Image source: Andreas Heddergott / TUM

When infected with the Sars-CoV-2 virus, the human body produces a series of immune responses. One of them involves platelets, also known as thrombocytes, sticking to immune cells to form clumps, or aggregates, of cells in the bloodstream. In a study using image-based flow cytometry, a team of researchers working with Oliver Hayden, a professor of biomedical electronics, demonstrated a rapid rise in concentrations of platelet aggregates in patients admitted to intensive care with Covid-19 infections. This enabled them to identify a biomarker for predicting the risk of severe illness in Covid-19 patients. The result was made possible by the optimal interdisciplinary conditions offered by the central TranslaTUM institute to TUM engineers for collaboration with medical researchers at Klinikum München rechts der Isar. 

The analysis began with a blood sample taken from the test subjects. A few drops of blood are needed to count thousands of blood cells and their aggregates within seconds using image-based flow cytometry. The head of the study, Prof. Hayden, says: “Another big advantage of this method is that we neither have to treat nor mark the samples. Using standardized methods, we can investigate them directly without aggregation losses caused by high shearing forces. In the future, this cost-effective method could help quantify interactions between the coagulation system and the immune system.” The close proximity of patients to the lab when taking samples permits the blood to be tested immediately. This rules out effects from the aging of samples, which also causes aggregates to form.

The researchers investigated blood samples from 36 intensive care patients (age 32 to 83) admitted to the hospital with a Sars-CoV-2 infection classified as moderate to severe. The results showed that the number of aggregated thrombocytes in the blood samples of severely ill patients was significantly higher than in moderately ill patients and definitely in healthy blood donors. 

With regard to the cell aggregates, the researchers found that the number of aggregates and their composition changed gradually in line with the severity of the Covid-19 infection and that these changes occurred at an early stage before complications appeared. The aggregates were typically made up of fewer than 10 thrombocytes. In extreme cases, it was observed that up to two thirds of all thrombocytes in a patient were aggregated. 

A high concentration of cell aggregates was seen in all Covid-19 patients admitted to intensive care. This simple diagnostic method based on blood cell aggregates has the potential to identify high-risk patients at an early stage and improve their care. The interdisciplinary team of engineers and medical researchers now plan to transfer what they have learned to other diseases. They believe that the method described here could also function with cardiovascular disease or cancers

Source: Technical University of Munich


Related articles


News • Preparing for the next pandemic

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.


News • "COMPASS" method

Using nanoparticles for more sensitive rapid tests

A newly developed rapid test needs only a few seconds to reliably detect pathogens such as SARS-CoV-2. It is based on specially designed magnetic nanoparticles.


News • Deep mutational scanning for SARS-CoV-2

Preparing rapid tests for future coronavirus variants

How can rapid antigen tests be adjusted to reliably detect future variants of SARS-CoV-2? A research team funded by the National Institutes of Health is currently working on finding an answer.

Related products

Subscribe to Newsletter